Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Human medicines: European public assessment reports (EPARs)
Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.
Follow now 257 followers
Latest posts
Last updated 30 minutes ago
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation: 14/02/2025, Status: Authorised
33 minutes ago
Human medicines European public assessment report (EPAR): Osenvelt, denosumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised
about 2 hours ago
Human medicines European public assessment report (EPAR): Rystiggo, Rozanolixizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 7, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation...
Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation: 19/05/2021, Revision: 3, Status: Authorised
about 3 hours ago
Human medicines European public assessment report (EPAR): Copiktra, duvelisib, Date of authorisation...
Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of authorisation: 20/05/2008, Revision: 26, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Extavia, interferon beta-1b, Date of...
Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation: 22/05/2014, Revision: 31, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Jardiance, empagliflozin, Date of authorisation...
Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation: 27/05/2015, Revision: 29, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Synjardy, empagliflozin,metformin, Date of authorisation...
Human medicines European public assessment report (EPAR): Pelmeg, pegfilgrastim, Date of authorisation: 20/11/2018, Revision: 10, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Pelmeg, pegfilgrastim, Date of authorisation...
Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 2, Status: Authorised
1 day ago
Human medicines European public assessment report (EPAR): BroPair Spiromax, salmeterol,fluticasone propionate, Date...
Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of authorisation: 20/07/2015, Revision: 15, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Bortezomib Accord, bortezomib, Date of...
Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation: 20/09/2018, Revision: 13, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Slenyto, melatonin, Date of authorisation...
Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation: 11/11/2016, Revision: 20, Status: Authorised
2 days ago
Human medicines European public assessment report (EPAR): Glyxambi, empagliflozin,linagliptin, Date of authorisation...